Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cassia Seed for Obesity in Schizophrenia
NCT04252131Phase 1Completed
- Sponsor
- Calo Psychiatric Center
- Start
- May 2018
- Primary completion
- Oct 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in obesity comparing Cassia seed with Cassia seed placebo (2 arms). Primary endpoints: Body Mass Index at 12 weeks and Waist Circumference at 12 weeks. Started May 2018; status: completed.
02
Drugs
cassia seed
03
Conditions
obesity
Beyond the preview
Go deeper on NCT04252131.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04252131.